Top Markets
Coin of the day
Elicio Therapeutics, Inc. Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc.

ELTX
शेयरों में रैंक #24601
Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to... Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG adjuvant that forms part of ELI-002; ELI-007, a lymph node-targeted AMP-peptide vaccine addressing mutant BRAF-driven cancers; and ELI-008, a multivalent lymph node-targeted AMP-peptide vaccine for cancers expressing mutant TP53. Furthermore, Elicio is advancing ELI-005, a vaccine candidate for preventing COVID-19, and ELI-011 for hematological malignancies. Another program, ELI-012, is an mKRAS TCR T cell AMP-lifier designed for combined use with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company's operations are headquartered in Boston, Massachusetts.
शेयर मूल्य
$3.09
मार्केट कैप
$58.82M
बदलाव (1 दिन)
0.33%
बदलाव (1 वर्ष)
-73.01%
देश
US
व्यापार Elicio Therapeutics, Inc. (ELTX)

श्रेणी

Elicio Therapeutics, Inc. (ELTX) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $3.10 (2026-08-01 को)

दिन का सबसे निम्न समापन मूल्य: $5.88 (2023-11-01 को)
Elicio Therapeutics, Inc. के स्टॉक मूल्य का इतिहास 2023 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
वर्ष प्रदर्शन
2026 (TTM) 9.17%
2025 59.27%
2024 -21.55%
2023 0.00%
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
कंपनी स्टॉक मूल्य परिवर्तन 1व% देश
$550.69 38.55%
US
$1.05K 58.44%
NL
$149.06 468.48%
US
$118.70 -18.24%
AU
$770.19 9.84%
CH